Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Visualized Experiments : Jove|September 30, 2016
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in MiceSantiago Uranga, Dessislava Marinova, Carlos Martin, et al.
Plos One|April 8, 2016
Granzyme A Is Expressed in Mouse Lungs during Mycobacterium tuberculosis Infection but Does Not Contribute to Protection In VivoSantiago Uranga, Dessislava Marinova, Carlos Martin, et al.
Tuberculosis (Edinburgh, Scotland)|January 21, 2016
MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn miceNacho Aguilo, Santiago Uranga, Dessislava Marinova, et al.
Nature Communications|March 9, 2024
Dependency on host vitamin B12 has shaped Mycobacterium tuberculosis Complex evolutionElena Campos-Pardos, Santiago Uranga, Ana Picó, et al.
The Journal of Infectious Diseases|October 24, 2015
Pulmonary but Not Subcutaneous Delivery of BCG Vaccine Confers Protection to Tuberculosis-Susceptible Mice by an Interleukin 17-Dependent MechanismNacho Aguilo, Samuel Alvarez-Arguedas, Santiago Uranga, et al.
Ebiomedicine|January 22, 2021
Therapeutic efficacy of pulmonary live tuberculosis vaccines against established asthma by subverting local immune environmentRaquel Tarancón, Elena Mata, Santiago Uranga, et al.
Ebiomedicine|August 22, 2024
Correlation between systemic allergen desensitisation and long-term asthma protection in mice following intravenous administration of the live tuberculosis vaccine MTBVACSilvia Calvo, Jose Manuel Rodrigo-Muñoz, Raquel Tarancón, et al.
Cancer Gene Therapy|August 2, 2025
NK cells mediate preventive efficacy of intravenous BCG against lung metastasis in miceClaudia Guerrero, Marta Casal, Cristina Alierta, et al.
Vaccine|July 29, 2014
Hyper-attenuated MTBVAC erp mutant protects against tuberculosis in miceLuis Solans, Santiago Uranga, Nacho Aguilo, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 28, 2018
Therapeutic efficacy of the live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in a preclinical model of bladder cancerSamuel Alvarez-Arguedas, Santiago Uranga, Manuel Martín, et al.
Pageof 3